Stay updated with breaking news from Inhibrx daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) insider Brendan P. Eckelman sold 300,000 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $34.30, for a total value of $10,290,000.00. Following the sale, the insider now directly owns 1,735,553 shares of the company’s stock, […] ....
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) shares saw an uptick in trading volume on Wednesday . 764,772 shares traded hands during trading, an increase of 19% from the previous session’s volume of 644,035 shares.The stock last traded at $34.26 and had previously closed at $34.14. Analyst Upgrades and Downgrades A number of brokerages have […] ....
Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) saw an uptick in trading volume on Monday . 1,719,541 shares were traded during trading, an increase of 139% from the previous session’s volume of 718,804 shares.The stock last traded at $34.92 and had previously closed at $34.97. Analyst Upgrades and Downgrades INBX has been the […] ....
Inhibrx (NASDAQ:INBX – Get Free Report) and Novavax (NASDAQ:NVAX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings […] ....
Inhibrx (NASDAQ:INBX) Reaches New 1-Year High at $39.79 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.